Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older
Clinical trial NCT06686654 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06686654
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-11
- Primary completion
- 2027-01-18
- Enrollment
- 1530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.